Search results for "chaperonopathies"

showing 10 items of 29 documents

Chaperonopathies of senescence and the scrambling of interactions between the chaperoning and the immune systems.

2010

Aging entails progressive deterioration of molecules and supramolecular structures, including Hsp chaperones and their complexes, paralleled by functional decline. Recent research has changed our views on Hsp chaperones. They work inside and outside cells in many locations, alone or forming teams, interacting with cells, receptors, and molecules that are not chaperones, in roles that are not typically attributed to chaperones, such as protein folding. Hsp chaperones form a physiological system with a variety of functions and interactions with other systems, for example, the immune system. We propose that chaperone malfunctioning due to structural damage or gene dysregulation during aging ha…

AgingProtein Foldingchaperonopathies by mistakeSettore BIO/16 - Anatomia Umanachaperoning systemImmune Systemchaperoning system interactionchaperonopathieCarrier Proteinschaperonotherapy Hsp60Molecular ChaperonesAnnals of the New York Academy of Sciences
researchProduct

Human chaperonin disease-causing mutations: study with a prokaryotic model.

2012

Chaperonopathies HspsSettore CHIM/08 - Chimica Farmaceutica
researchProduct

Myelin pathology: Involvement of molecular chaperones and the promise of chaperonotherapy

2019

The process of axon myelination involves various proteins including molecular chaperones. Myelin alteration is a common feature in neurological diseases due to structural and functional abnormalities of one or more myelin proteins. Genetic proteinopathies may occur either in the presence of a normal chaperoning system, which is unable to assist the defective myelin protein in its folding and migration, or due to mutations in chaperone genes, leading to functional defects in assisting myelin maturation/migration. The latter are a subgroup of genetic chaperonopathies causing demyelination. In this brief review, we describe some paradigmatic examples pertaining to the chaperonins Hsp60 (HSPD1,…

ChaperonotherapyMyelinopathiechaperonopathiescctlcsh:RC321-571Chaperonin03 medical and health sciencesMyelin0302 clinical medicinemedicineAxonlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryGene030304 developmental biologyMyelinopathies0303 health sciencesbiologyGeneral NeuroscienceHsp60medicine.anatomical_structureMyelinChaperone (protein)PerspectiveProteinopathiesbiology.proteinChaperonopathiemyelinopathiesHSP60Neuroscience030217 neurology & neurosurgeryMyelin pathology
researchProduct

Hsp60 molecular anatomy and role in colorectal cancer diagnosis and treatment

2011

Quantitative changes in Hsp60 during the development of some tumors suggest that this chaperonin plays a role in carcinogenesis. A description of the specific role(s) of Hsp60 in tumor-cell growth and proliferation is still incomplete, but it is already evident that monitoring its levels and distribution in tissues and fluids has potential for diagnosis and staging, and for assessing prognosis and response to treatment. Although Hsp60 is considered an intramitochondrial protein, it has been demonstrated in the cytosol, cell membrane, vesicles, cell surface, extracellular space, and blood. The knowledge that Hsp60 occurs at all these locations opens new avenues for basic and applied research…

Clinical OncologyOncologymedicine.medical_specialtyGeneral Immunology and Microbiologybusiness.industryColorectal cancerCellChaperonin 60medicine.disease_causeBioinformaticsmedicine.diseaseResponse to treatmentGeneral Biochemistry Genetics and Molecular BiologyChaperoninmedicine.anatomical_structureInternal medicineBiomarkers TumorHumansMedicineHSP60Chaperoning system Chaperonology Chaperonopathies Chaperonotherapy Hsp60 Clinical oncology Colorectal cancer ReviewColorectal NeoplasmsbusinessCarcinogenesisFrontiers in Bioscience
researchProduct

The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19

2020

The COVID-19 pandemic made imperative the search for means to end it, which requires a knowledge of the mechanisms underpinning the multiplication and spread of its cause, the coronavirus SARS-CoV-2. Many viruses use members of the hosts’ chaperoning system to infect the target cells, replicate, and spread, and here we present illustrative examples. Unfortunately, the role of chaperones in the SARS-CoV-2 cycle is still poorly understood. In this review, we examine the interactions of various coronaviruses during their infectious cycle with chaperones in search of information useful for future research on SARS-CoV-2. We also call attention to the possible role of molecular mimicry in the dev…

Coronavirus disease 2019 (COVID-19)CoronaviridaevirusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:MedicineReviewComputational biologyvirusmedicine.disease_causechaperonopathiesVirusEpitopeAutoimmunity03 medical and health sciences0302 clinical medicinemedicineCoronaviridaechaperonotherapy030304 developmental biologyCoronavirus0303 health sciencesbiologybusiness.industrySARS-CoV-2lcsh:Rmolecular chaperonesCOVID-19General Medicinemolecular chaperonebiology.organism_classificationMolecular mimicry030220 oncology & carcinogenesischaperonopathiebusiness
researchProduct

Lipid chaperones and associated diseases: a group of chaperonopathies defining a new nosological entity with implications for medical research and pr…

2020

AbstractFatty acid–binding proteins (FABPs) are lipid chaperones assisting in the trafficking of long-chain fatty acids with functions in various cell compartments, including oxidation, signaling, gene-transcription regulation, and storage. The various known FABP isoforms display distinctive tissue distribution, but some are active in more than one tissue. Quantitative and/or qualitative changes of FABPs are associated with pathological conditions. Increased circulating levels of FABPs are biomarkers of disorders such as obesity, insulin resistance, cardiovascular disease, and cancer. Deregulated expression and malfunction of FABPs can result from genetic alterations or posttranslational mo…

Gene isoformChaperonotherapyBiomedical ResearchDiseaseBioinformaticsFatty Acid-Binding ProteinsBiochemistryModels BiologicalFatty acid–binding proteinsFatty acid-binding proteinPathogenesisInsulin resistanceSettore BIO/10 - BiochimicaMedicineAnimalsHumansDiseasePathologicalLipid chaperonesbusiness.industrySettore BIO/16 - Anatomia UmanaCancerCell BiologyChaperonopathiesmedicine.diseaseLipidslipids (amino acids peptides and proteins)Metabolic syndromePerspective and Reflection ArticlebusinessLipid chaperone-associate pathologiesMolecular ChaperonesCell stresschaperones
researchProduct

Hsp10: Anatomic distribution, functions, and involvement in human disease

2013

There is growing evidence that molecular chaperones/heat shock proteins are involved in the pathogenesis of a number of human diseases, known as chaperonopathies. A better molecular understanding of the pathogenetic mechanisms is essential for addressing new strategies in diagnostics, therapeutics and clinical management of chaperonopathies, including those in which Hsp10 is involved. This chaperonin has been studied for a long time as a member of the mitochondrial protein-folding machine. However, although in normal cells Hsp10 is mainly localized in the mitochondrial matrix, it has also been found during and after stress in other subcellular compartments, such as cytosol, vesicles and sec…

InflammationAgingGeneral Immunology and MicrobiologySettore BIO/16 - Anatomia UmanaVesicleBiologyGeneral Biochemistry Genetics and Molecular BiologyChaperoninCell biologyAutoimmune DiseasesPathogenesisSettore MED/18 - Chirurgia GeneraleCytosolSettore MED/38 - Pediatria Generale E SpecialisticaBiochemistryMitochondrial matrixHeat shock proteinNeoplasmsCancer cellExtracellularChaperonin 10HumansHsp10chaperonopathies molecular chaperones human diseases cellular localization mitochondria
researchProduct

Hsp60 chaperonopathies and chaperonotherapy: targets and agents

2014

Hsp60 (Cpn60) assembles into a tetradecamer that interacts with the co-chaperonin Hsp10 (Cpn10) to assist client polypeptides to fold, but it also has other roles, including participation in pathogenic mechanisms.Hsp60 chaperonopathies are pathological conditions, inherited or acquired, in which the chaperone plays a determinant etiologic-pathogenic role. These diseases justify selection of Hsp60 as a target for developing agents that interfere with its pathogenic effects. We provide information on how to proceed.The information available encourages the development of ways to improve Hsp60 activity (positive chaperonotherapy) when deficient or to block it (negative chaperonotherapy) when pa…

InflammationPharmacologyanimal structuresChaperonin 60biologyProtein ConformationfungiClinical BiochemistryChaperonin 60BioinformaticsAutoimmune Diseasesautoimmunity cancer carboranylphenoxyacetanilide chaperonopathies chaperonotherapy chemical compounds Cpn60 electrophilic compounds epolactaene functional domain GroEL Hsp60 inflammation mizoribine structural domainNeoplasmsChaperone (protein)Expert opinionDrug DiscoveryImmunologybiology.proteinAnimalsHumansMolecular MedicineHSP60Cytokine formationA determinantExpert Opinion on Therapeutic Targets
researchProduct

The triad hsp60-mirnas-extracellular vesicles in brain tumors: Assessing its components for understanding tumorigenesis and monitoring patients

2021

Brain tumors have a poor prognosis and progress must be made for developing efficacious treatments, but for this to occur their biology and interaction with the host must be elucidated beyond current knowledge. What has been learned from other tumors may be applied to study brain tumors, for example, the role of Hsp60, miRNAs, and extracellular vesicles (EVs) in the mechanisms of cell proliferation and dissemination, and resistance to immune attack and anticancer drugs. It has been established that Hsp60 increases in cancer cells, in which it occurs not only in the mitochondria but also in the cytosol and plasma-cell membrane and it is released in EVs into the extracellular space and in cir…

Molecular chaperonesCellBrain tumorBiologymedicine.disease_causelcsh:Technologylcsh:Chemistry03 medical and health sciences0302 clinical medicineImmune systemHigh-grade gliomaExtracellularmedicineGeneral Materials Sciencelcsh:QH301-705.5Instrumentation030304 developmental biologyFluid Flow and Transfer Processes0303 health sciencesLiquid biopsylcsh:TProcess Chemistry and TechnologyGeneral EngineeringCancerTumor biomarkersChaperonopathiesExtracellular vesiclesmedicine.diseaseHsp60lcsh:QC1-999Computer Science ApplicationsCrosstalk (biology)medicine.anatomical_structurelcsh:Biology (General)lcsh:QD1-999lcsh:TA1-2040030220 oncology & carcinogenesisCancer cellCancer researchChaperone systemMiRNAslcsh:Engineering (General). Civil engineering (General)CarcinogenesisGlioblastomaMeningiomalcsh:Physics
researchProduct

A Novel CCT5 Missense Variant Associated with Early Onset Motor Neuropathy

2020

Diseases associated with acquired or genetic defects in members of the chaperoning system (CS) are increasingly found and have been collectively termed chaperonopathies. Illustrative instances of genetic chaperonopathies involve the genes for chaperonins of Groups I (e.g., Heat shock protein 60, Hsp60) and II (e.g., Chaperonin Containing T-Complex polypeptide 1, CCT). Examples of the former are hypomyelinating leukodystrophy 4 (HLD4 or MitCHAP60) and hereditary spastic paraplegia (SPG13). A distal sensory mutilating neuropathy has been linked to a mutation [p.(His147Arg)] in subunit 5 of the CCT5 gene. Here, we describe a new possibly pathogenic variant [p.(Leu224Val)] of the same subunit b…

Mutation.Hereditary spastic paraplegiaProtein subunitchaperoning systemMutation MissenseBiologyMolecular Dynamics Simulationmedicine.disease_causeCatalysisArticleChaperoninInorganic Chemistrylcsh:ChemistryHeat shock proteinmedicineMissense mutationHumansPhysical and Theoretical Chemistrymotor neuropathyAge of OnsetGenetic variantMolecular BiologyGenelcsh:QH301-705.5SpectroscopyExome sequencingMyelin SheathGenetic chaperonopathieGeneticsMutationgenetic variantsOrganic ChemistryInfant NewbornGeneral Medicinemedicine.diseasePhenotypeComputer Science ApplicationsCCT5; chaperoning system; chaperonins; genetic chaperonopathies; genetic variants; motor neuropathy; mutationPhenotypelcsh:Biology (General)lcsh:QD1-999chaperoninsFemaleCCT5mutationHereditary Sensory and Motor Neuropathygenetic chaperonopathiesChaperonin Containing TCP-1International Journal of Molecular Sciences
researchProduct